MNX1 and nasopharyngeal carcinoma: AcRoots has also demonstrated its tumor-suppressing potential in nasopharyngeal carcinoma by inhibiting the E2F1-mediated MNX1-AS1 expression, thus hindering cell proliferation and metastasis [25].